WuXi's SynTheAll Manufacturing Subsidiary Opens San Diego Facility

WuXi AppTec, the China CRO/CMO, announced that Shanghai SynTheAll Pharma (STA), WuXi's small-molecule process development and manufacturing subsidiary, is opening a San Diego site. The new facility, the first US presence for STA, will provide process R&D and API manufacturing services for early phase clinical studies. The San Diego facility will join three other sites, all of them in China: STA has two facilities in Shanghai, and it opened a new $100 million Chengdu facility in February of this year. More details.... Share this with colleagues: // //